about
Changes in calcanean bone mineral occurring spontaneously and during hormone replacement therapy in early post-menopausal women.The impact of idiopathic childhood-onset growth hormone deficiency (GHD) on bone mass in subjects without adult GHD.Abnormal bone collagen morphology and decreased bone strength in growth hormone-deficient rats.Should measurement of body composition influence therapy for obesity?Bone mineral density in diabetes mellitus patients with and without a Charcot foot.Body composition in italian and Danish women.Measurements of bone mineral density of the proximal femur by two commercially available dual energy X-ray absorptiometric systems.The Diabetic Foot in a Multidisciplinary Team Setting. Number of Amputations below Ankle Level and Mortality.Clinical management of acute diabetic Charcot foot in Denmark.The management of diabetic foot ulcers in Danish hospitals is not optimal.The effect of oral loading doses of cholecalciferol on the serum concentration of 25-OH-vitamin-D.Sarcopenia and body composition in diabetic Charcot osteoarthropathy.Effects of oral glucose load on endothelial function and on insulin and glucose fluctuations in healthy individuals.The effect of hormone replacement therapy on appendicular lean tissue mass in early postmenopausal women.Are soft tissue composition of bone and non-bone pixels in spinal bone mineral measurements by DXA similar? Impact of weight loss.An audit of the insulin-tolerance test in 255 patients with pituitary disease.Comparisons of leptin, incretins and body composition in obese and lean patients with hypopituitarism and healthy individuals.Abnormal sympathoadrenal activity, but normal energy expenditure in hypopituitarism.High risk of adrenal insufficiency in adults previously treated for idiopathic childhood onset growth hormone deficiency.Combined dietary and pharmacological weight management in obese hypopituitary patients.[Pharmacotherapy of obesity].Effects of acute and chronic attenuation of postprandial hyperglycemia on postglucose-load endothelial function in insulin resistant individuals: is stimulation of first phase insulin secretion beneficial for the endothelial function?Duration of off-loading and recurrence rate in Charcot osteo-arthropathy treated with less restrictive regimen with removable walker.Measurements of body composition by dual-energy X-ray absorptiometry improve prediction of energy expenditure.Bone mineral density and markers of bone turnover and inflammation in diabetes patients with or without a Charcot foot: An 8.5-year prospective case-control study.Long-term effects on the progress of neuropathy after diabetic Charcot foot: an 8.5-year prospective case-control study.Diabetic ketoacidosis in Denmark Incidence and mortality estimated from public health registries.Treatment of diabetic ketoacidosis in adults in Denmark: a national survey.[Treatment of diabetic ketoacidosis in adults in Denmark--need for national guidelines. Secondary publication].[Diabetic ketoacidosis in Denmark--registry-based estimation of incidence and mortality. Secondary publication].Risk Factors for Premature Death in Diabetes Patients who Undergo Amputations below Ankle Level.[Obesity in Danish hospitals--treatment in the year 2000].[Obesity in Danish hospitals--attitudes in the year 2000].[Charcot's arthropathy].Plasminogen activator inhibitor-1, tissue-type plasminogen activator, and fibrinogen: Effect of dieting with or without exercise in overweight postmenopausal women.Comparison of resting energy expenditure measurements by ventilated canopy and by respiration chamber.Anteroposterior and lateral spinal DXA for the assessment of vertebral body strength: comparison with hip and forearm measurement.40 EASD Annual Meeting of the European Association for the Study of Diabetes : Munich, Germany, 5-9 September 200440th EASD Annual Meeting of the European Association for the Study of DiabetesMortality and complications after treatment of acute diabetic Charcot foot
P50
Q30804895-7D2FF3CA-F33C-49B9-8DF7-0811F1F4D393Q31139824-E969B493-F838-4C97-94CF-3E6CB97AFDB5Q33203981-5F191F33-B5DB-45B4-B16D-41527C217E9EQ35584232-BD62A784-D848-4051-AF93-312ABA542E63Q38489285-5AB8DA79-3C53-49D9-A560-4C9DBD32B1EFQ38526143-F10E1F69-E515-4DC5-9C9C-49CD60B91ADBQ38533702-39CC209B-0151-46D0-A817-E5AC7B50FB70Q39581167-18F7F0E9-1231-48ED-8A26-48C57D53D57AQ40556234-60706A33-B56E-4C0C-BB36-D6053CECBDB2Q40876455-A5A8C263-1A97-4FE4-9D1F-8BCF90BEEE35Q41122472-E07D300A-75DB-4839-A120-353B78C2F463Q41615909-FCC81E5E-CDB3-452B-BED2-0C08A5C8F7C4Q42604482-5104A686-1F9D-4289-B0E2-46BEB898F09AQ43903439-BE290B93-4A47-4F16-B43D-AA4BF010D6A1Q43987972-B9DB94C3-2286-4C34-88FA-9CC13AD7D667Q44044552-D96C1F74-BD34-4A81-BDEC-0B116251E8D8Q44272959-2229E5ED-24FB-4C03-B04F-F06F5D8A3F88Q44690225-055E5A3F-B570-4979-B0FB-67158F66475FQ44690257-F33CDE96-8F86-45D9-B37E-CA2C4136ED27Q45188956-7AF35616-0BE6-4D3A-8B8B-F3A704FE7DCDQ46230352-53724E6D-152C-45EC-9159-7BA5746F7D8FQ46367083-3F291C2E-C668-4D07-A50D-F9F2EB194EB6Q47621333-8ABD92FF-1D02-413F-ACD9-6AB2E32C4E84Q48719366-FADC5D07-EABC-4F7B-B253-D6294E098DE1Q49357932-0A414CE5-83BF-4682-8810-DCE18A43FA78Q49842882-9A040D28-E771-49C7-A201-DDD84BCEBEA0Q50544226-17509262-22B6-4140-9F13-DA19B0C6456AQ50544498-F3EBEC63-5242-4116-9BBB-F8169BD9D255Q50545690-9AD3E4AC-112C-4EBE-8160-7B9E7372126FQ50545694-2AEDA73F-ADE3-4B88-B189-2A05DAC4879BQ50546683-D43DA0FC-AF10-4405-8883-6252D9B16040Q50571379-F203C5FD-C337-4719-861D-313EA9E4A500Q50571382-BA9D32E1-D6D8-4811-B2B9-6ED1E86C2F7EQ50636506-00FDE8A4-6A3E-4B64-AA38-C725D8F98C67Q51033201-D8C10696-7BB2-4036-A7D9-6733E2463943Q52206813-521D0C46-66EB-4AE1-A1D1-A5F6DE3A446DQ52317757-EC87AF66-9049-43FC-8ABB-0FACE8D43B1FQ56836084-DAEF6BE5-ADB3-4349-AFC9-49B0F7F4407FQ57249806-2C69BBA9-61CF-4152-83E4-655C4848C06FQ57299728-22785453-7900-4C58-8049-4720AD422F36
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Ole Lander Svendsen
@ast
Ole Lander Svendsen
@en
Ole Lander Svendsen
@es
Ole Lander Svendsen
@nl
Ole Lander Svendsen
@sl
type
label
Ole Lander Svendsen
@ast
Ole Lander Svendsen
@en
Ole Lander Svendsen
@es
Ole Lander Svendsen
@nl
Ole Lander Svendsen
@sl
prefLabel
Ole Lander Svendsen
@ast
Ole Lander Svendsen
@en
Ole Lander Svendsen
@es
Ole Lander Svendsen
@nl
Ole Lander Svendsen
@sl
P106
P21
P31
P496
0000-0003-2846-9532